Captrust Financial Advisors lifted its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 5.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,481 shares of the financial services provider’s stock after acquiring an additional 737 shares during the period. Captrust Financial Advisors’ holdings in iShares Nasdaq Biotechnology ETF were worth $1,736,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of IBB. McKinley Carter Wealth Services Inc. acquired a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter worth about $29,000. NWK Group Inc. acquired a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter worth about $29,000. Financial Advisory Service Inc. acquired a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter worth about $32,000. Advanced Asset Management Advisors Inc acquired a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter worth about $36,000. Finally, Quadrant Capital Group LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter worth about $39,000. 89.19% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ:IBB opened at $102.00 on Thursday. The stock’s 50-day moving average price is $113.95 and its two-hundred day moving average price is $112.63. iShares Nasdaq Biotechnology ETF has a 12-month low of $92.15 and a 12-month high of $123.92.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Thursday, March 26th will be paid a $0.0554 dividend. This represents a $0.22 dividend on an annualized basis and a yield of 0.22%. The ex-dividend date is Wednesday, March 25th.

Separately, ValuEngine lowered iShares Nasdaq Biotechnology ETF from a “hold” rating to a “sell” rating in a research note on Tuesday.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More: What is the accumulation/distribution indicator?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.